Publications

Found 6 results

2024
Jalencas X, Berg H, Espeland LO, Sreeramulu S, Kinnen F, Richter C, Georgiou C, Yadrykhinsky V, Specker E, Jaudzems K et al..  2024.  Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection. RSC Med. Chem..
Altincekic* N, Jores N, Löhr F, Richter C, Ehrhardt C, Blommers MJJ, Berg H, Öztürk S, Gande SL, Linhard V et al..  2024.  Targeting main protease (Mpro, nsp5) by growth of fragment scaffolds exploiting structure-based methodologies. ACS Chem. Biol. . 19:563-574.
2022
Berg H, Martin WMA, Altincekic N, Alshamleh I, Bains KJ, Blechar J, Ceylan B, de Jesus V, Dhamotharan K, Fuks C et al..  2022.  Exploring the druggability of conserved RNA regulatory elements in the SARS-CoV-2 genome. Angew. Chem. Intl. Ed.. 61:e202205858.
2021
Sreeramulu S, Richter C, Berg H, Martin WMA, Ceylan B, Matzel T, Adam J, Altincekic N, Azzaoui K, Bains KJ et al..  2021.  Exploring the druggability of conserved RNA regulatory elements in the SARS-CoV-2 genome. Angew. Chem. Int. Ed. Engl.. 60:19191-19200.
Berg H, Martin WM, Niesteruk A, Richter C, Sreeramulu S, Schwalbe H.  2021.  NMR-based fragment screening in a minimum sample but maximum automation mode. J. Vis. Exp.. :e62262.
2020
Binas O, de Jesus V, Landgraf T, Völklein AE, Martins J, Hymon D, Bains KJ, Berg H, Biedenbänder T, Fürtig B et al..  2020.  19F-NMR-based fragment screening for 14 different biologically active RNAs and 10 DNA and protein counter-screens. ChemBioChem.